Evidence map›Paper›PMID 14751843›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2004

The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction.

Michel A Pontari, Alan S Braverman, Michael R Ruggieri

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 105 citations in OpenAlex.

  1. PIEZO1-mediated mechanosensation links aging to bladder dysfunction.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Big-conductance CaChannels (Austin, Tex.) · 2016
    Review
  8. Article
  9. Medical management of neurogenic bladder with oral therapy.Translational andrology and urology · 2016
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Management of urinary incontinence.P & T : a peer-reviewed journal for formulary management · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michel A PontariTemple University School of Medicine, 3400 N. Broad St., 715 OMS, Philadelphia, PA 19140-5104, USA.
Alan S Braverman
Michael R Ruggieri
Temple University · US

Funding

URINARY BLADDER MUSCARINIC RECEPTOR SUBTYPESR01DK043333 · NIDDK · TEMPLE UNIVERSITY · PI RUGGIERI, MICHAEL RAYMOND · 1991 to 2003
$998k
NIDDK NIH HHS DK 43333NIDDK NIH HHS R01 DK043333
6 · The paper itself

Abstract

Bladder muscle specimens from seven patients with neurogenic bladder dysfunction were analyzed to determine whether the muscarinic receptor subtype mediating contraction shifts from M(3) to the M(2) subtype as found in the denervated, hypertrophied rat bladder. Seven bladder specimens were analyzed from six female and one male patients. Six of the patients had traumatic cervical spinal cord injuries (C(4)-C(7)), and the other patient had an L(1) congenital myelomeningocele. This was compared with results from bladder specimens obtained from eight organ transplant donors. The affinities of three subtype-selective muscarinic receptor antagonists for inhibition of carbachol-induced contractions were determined. The affinity of the M(3) selective antagonists darifenacin or p-fluoro-hexahydrosiladifenadol (p-F-HHSiD) was determined in six of the seven spinal injury patient specimens. The affinity was consistent with M(2)-mediated contractions in four of these six specimens, intermediate between M(2) and M(3) in one specimen, and within the M(3) range in one specimen. The other specimen, tested only with the M(2) selective antagonist methoctramine, showed an M(3) affinity. In the organ donors, the affinity of p-F-HHSiD was within the M(2) range for six of seven specimens, whereas the affinity of darifenacin was within the M(3) range for five of six and intermediate between M(2) and M(3) for the other specimen tested. The affinity of methoctramine in both organ donor specimens tested was within the M(3) range. Whereas normal detrusor contractions are mediated by the M(3) receptor subtype, in patients with neurogenic bladder dysfunction as well as certain organ transplant donors, contractions can be mediated by the M(2) muscarinic receptor subtype.

Indexed as

AdolescentAdultDiaminesFemaleHumansIn Vitro TechniquesMaleMuscarinic AntagonistsMuscle ContractionMuscle, SmoothParasympatholyticsReceptor, Muscarinic M2Receptor, Muscarinic M3Spinal Cord InjuriesUrinary BladderUrinary Bladder, NeurogenicDiaminesmethoctramineMuscarinic AntagonistsParasympatholyticsReceptor, Muscarinic M2Receptor, Muscarinic M3

Identifiers

PMID14751843
PMCPMC3274770
OpenAlexW2144402083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.